• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • LinkedIn
  • YouTube
  • Instagram
  • X
  • Contact Us
  • Clinical Trials
  • Careers
  • Investors
Insmed Insmed

Insmed

  • Company

    Company

    Get to know Insmed, see what drives us, and learn how weโ€™re building a company where people come first.

    Learn about our company

    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients

    Patients

    See how we collaborate with patients to shape every step of our shared journey.

    Learn about our
    commitment to patients

    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access

    Current Clinical Trials

    Learn more about our clinical trials or find a relevant trial near you.

    See if you may qualify

  • Science

    Science

    Discover the innovative science that fuels our commitment to delivering breakthroughs.

    Learn about our science

    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies

    Therapies

    Learn about our therapies

    • ARIKAYCEยฎ
    • BRINSUPRIยฎ
  • Responsibility

    Responsibility

    See how weโ€™re continuing to advance science sustainably and ethically.

    Learn about our
    commitment to responsibility

      • Global Healthcare Compliance
      • Policies & Disclosures

    Responsibility in Action

    Our commitment to responsibility reflects the culture and purpose we live by every day.

    Visit our Responsibility site

  • Company
    • Company
    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships
  • Patients
    • Patients
    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access
  • Science
    • Science
    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies
    • Therapies
    • ARIKAYCEยฎ
      BRINSUPRIยฎ
  • Responsibility
    • Responsibility
    • Global Healthcare Compliance
    • Policies & Disclosures
  • Investors
  • Press Releases
  • Events & Presentations
  • Financials & Filings
    • Earnings Results
    • Annual Reports
    • SEC Filings
  • Corporate Governance
  • Responsibility Reports
  • Resources
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts

Press Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • May 3, 2016
    Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting

    Read more

  • Mar 2, 2016
    Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference

    Read more

  • Feb 25, 2016
    Insmed Reports Fourth Quarter 2015 Financial Results

    Read more

  • Jan 5, 2016
    Insmed to Present at the 34th Annual J.P. Morgan Healthcare Conference

    Read more

  • Nov 24, 2015
    Insmed to Present at the Piper Jaffray 27th Annual Healthcare Conference

    Read more

  • Nov 11, 2015
    Insmed to Present at the Stifel 2015 Healthcare Conference

    Read more

  • Nov 6, 2015
    Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update

    Read more

  • Oct 31, 2015
    Insmed to Host Third Quarter 2014 Financial Results Conference Call on Thursday, November 6, 2014

    Read more

  • Oct 29, 2015
    Insmed to Host Third Quarter 2015 Financial Results Conference Call on Friday, November 6, 2015

    Read more

  • Oct 26, 2015
    Insmed Announces Upcoming Data Presentation at AMCP Nexus 2015

    Read more

  • Oct 19, 2015
    The Balancing Act(R) on Lifetime to Feature NTM Lung Disease

    Read more

  • Oct 14, 2015
    INSMED Launches Comprehensive Educational Campaign to Raise Awareness of NTM Lung Disease
    NTMfacts.com Provides a Dynamic Resource for Healthcare Providers to Learn More About NTM Lung Disease Through Patient Testimonials and Case Studies

    Read more

  • Oct 6, 2015
    Insmed Announces Upcoming Data Presentations at Infectious Disease Week 2015

    Read more

  • Sep 22, 2015
    Insmed Announces Upcoming Data Presentations at ERS 2015

    Read more

  • Sep 14, 2015
    Insmed Announces Upcoming Data Presentations at ICAAC/ICC 2015

    Read more

  • Sep 5, 2015
    Insmed to Present at the Rodman & Renshaw Annual Global Investment Conference

    Read more

  • Sep 3, 2015
    Insmed to Present at the Leerink Partners Rare Disease Roundtable

    Read more

  • Aug 11, 2015
    Insmed Announces Proposed Public Offering of Common Stock

    Read more

  • Aug 6, 2015
    Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update

    Read more

  • Jul 28, 2015
    Insmed to Host Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015

    Read more

  • Jun 17, 2015
    Insmed to Participate at the JMP Securities Life Sciences Conference

    Read more

  • May 13, 2015
    Insmed Announces Upcoming Data Presentations at the American Thoracic Society 2015 International Meeting

    Read more

  • May 11, 2015
    Insmed to Participate at the UBS Global Healthcare Conference

    Read more

  • May 7, 2015
    Insmed Reports First Quarter 2015 Financial Results

    Read more

  • Apr 6, 2015
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares

    Read more

  • Mar 31, 2015
    Insmed Announces Pricing of Public Offering of Common Stock

    Read more

  • Mar 30, 2015
    Insmed Announces Proposed Public Offering of Common Stock

    Read more

  • Mar 27, 2015
    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Read more

  • Mar 23, 2015
    Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer
    20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases

    Read more

  • Feb 27, 2015
    Insmed Reports 2014 Fourth Quarter and Full Year Financial Results
    Marketing Authorization Application for ARIKAYCETM Validated by the European Medicines Agency

    Read more

  • Feb 24, 2015
    Insmed to Participate at Cowen & Company's 35th Annual Health Care Conference

    Read more

  • Jan 28, 2015
    Insmed to Participate at February Investment Conferences

    Read more

  • Jan 13, 2015
    Insmed Incorporated Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Read more

  • Jan 6, 2015
    Insmed to Present at the 33rd Annual J.P. Morgan Healthcare Conference

    Read more

  • Dec 15, 2014
    Insmed Provides End of Year Regulatory and Clinical Update

    Read more

  • Dec 15, 2014
    Insmed Appoints Myrtle Potter to its Board of Directors
    Pharmaceutical executive brings 30 years of commercial and operations leadership

    Read more

  • Nov 26, 2014
    Insmed to Participate at December Investment Conferences

    Read more

  • Nov 6, 2014
    Insmed Reports Third Quarter 2014 Financial Results
    Conference Call Begins Today at 8:30 a.m. Eastern Time

    Read more

  • Sep 24, 2014
    Insmed to Participate in Leerink Partners' Rare Disease Roundtable

    Read more

  • Sep 3, 2014
    Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014

    Read more

  • Aug 18, 2014
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares

    Read more

  • Aug 12, 2014
    Insmed Announces Pricing of Public Offering of Common Stock

    Read more

  • Aug 6, 2014
    Insmed Reports Second Quarter 2014 Financial Results

    Read more

  • Aug 4, 2014
    Insmed Provides Regulatory Update for ARIKAYCE
    Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications

    Read more

  • Jun 20, 2014
    Insmed to Present at the JMP Securities Healthcare Conference

    Read more

  • May 29, 2014
    Insmed Appoints David R. Brennan to Its Board of Directors

    Read more

  • May 20, 2014
    Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
    Poster Presentation at the American Thoracic Society Annual Meeting 2014

    Read more

  • May 13, 2014
    Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting

    Read more

  • May 12, 2014
    Insmed to Participate in the Bank of America Merrill Lynch 2014 Health Care Conference

    Read more

  • May 8, 2014
    Insmed Reports First Quarter 2014 Financial Results

    Read more

Show 5102550100 per page
  • «
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 16
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Sign Up

Investor Presentation

View the latest Insmed Investor Presentation

Download

Footer

Insmed

LinkedIn YouTube Instagram X

Terms of Use Privacy Policy California Notice at Collection U.S. Consumer Health Data Privacy Policy Your Privacy ChoicesCookie Settings

ยฉ 2026 Insmed Incorporated. All Rights Reserved.

You are now leaving Insmed's website.

Insmed does not control, review, or endorse third-party websites, and you agree that Insmed is not responsible for the content of the website you are about to enter.